Recently, Liu et al reported that TMEM166 is down-regulated in Lenvatinib-resistant HCC cells, and TMEM166 knockdown induces lenvatinib resistance in HCC cells while TMEM166 overexpression reverses it in vitro and in vivo [50]. Here, EVA1A is linked to hepatocellular carcinoma.